Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
516.01M | 493.61M | 427.79M | 379.51M | 310.64M |
Gross Profit | ||||
198.78M | 180.73M | 103.36M | 113.15M | 104.86M |
EBIT | ||||
73.82M | 56.49M | 3.06M | 24.59M | 30.86M |
EBITDA | ||||
71.53M | 58.61M | 14.06M | 26.66M | 46.52M |
Net Income Common Stockholders | ||||
55.95M | 46.63M | 7.81M | 19.02M | 32.66M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
164.67M | 132.54M | 19.63M | 28.69M | 72.18M |
Total Assets | ||||
362.38M | 285.68M | 197.76M | 197.48M | 183.86M |
Total Debt | ||||
435.00K | 1.22M | 48.00K | 76.00K | 25.06M |
Net Debt | ||||
-164.23M | -131.32M | -19.58M | -28.61M | -47.13M |
Total Liabilities | ||||
103.56M | 83.25M | 56.66M | 74.31M | 81.56M |
Stockholders Equity | ||||
258.82M | 202.44M | 141.09M | 123.17M | 102.22M |
Cash Flow | Free Cash Flow | |||
42.90M | 106.56M | -11.92M | -16.72M | 32.93M |
Operating Cash Flow | ||||
42.90M | 107.16M | -10.94M | -16.17M | 33.32M |
Investing Cash Flow | ||||
-974.00K | -594.00K | -982.00K | -557.00K | -375.00K |
Financing Cash Flow | ||||
-8.30M | 6.29M | 3.03M | -26.80M | 2.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $7.91B | 80.52 | 12.54% | ― | 2.85% | -43.53% | |
76 Outperform | $56.31B | 38.99 | 21.27% | ― | 4.94% | -4.13% | |
74 Outperform | $204.72B | 21.48 | 52.42% | 3.57% | 0.42% | 5.77% | |
73 Outperform | $302.84B | 28.60 | 41.86% | 2.76% | 1.96% | -0.45% | |
69 Neutral | $3.92B | 21.12 | 40.81% | ― | 0.34% | 9.48% | |
64 Neutral | $1.70B | 31.57 | 24.26% | ― | 4.54% | 19.37% | |
63 Neutral | $20.66B | 14.30 | -10.05% | 3.14% | 1.30% | 2.76% |
On March 26, 2025, The Vita Coco Company issued a press release addressing a short seller report by NINGI Research, which held a short position in the company’s stock. The company refuted the report’s claims, citing inaccuracies and reaffirmed its fiscal year 2025 outlook and long-term growth strategy. Despite past inventory constraints affecting private label service levels, the company remains confident in its governance and financial practices, with no material changes since its last earnings call.